I queried an officeholder on this exact point several months ago and the response was that Epichem is profitable. (actually I asked whether I could obtain a copy of the subsidiary's (Epichem) financial statements too but was declined on that front).
My question to you - how do you arrive at conclusion that Epichem is not profitable?
Epichem has a compound annual growth rate of 30% and international ISO accreditations are expected later this year which will boost demand even higher. I think it would be foolish to scale back this operation.
Ann: Appendix 4C - Quarterly Report & Brief Company Update, page-7
-
- There are more pages in this discussion • 22 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PAA (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
21.5¢ |
Change
0.010(4.88%) |
Mkt cap ! $104.6M | |||
| Open | High | Low | Value | Volume |
| 20.5¢ | 21.5¢ | 20.5¢ | $244.1K | 1.163M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 71981 | 21.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 21.5¢ | 84173 | 3 |
View Market Depth
| Last trade - 16.10pm 11/10/2024 (20 minute delay) ? |
| PAA (ASX) Chart |